
Fauciã¯ãã¯ã¯ãã³ã§ã³ãããæ¢ããããšãããã¹ãŠã®ãç§åŠããããŸããããªãããšãèªããŸããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
(ããã¥ã©ã«ã»ãã¥ãŒã¹ïŒä»é±ãæŠæŒ¢ã³ãããŠã€ã«ã¹ïŒCovid-19ïŒã®ãã¯ã¯ãã³ãå®éšã«ã€ããŠã³ã¡ã³ãããåç±³åœã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒæé·ãããŒã»ãã¡ãŠãããæ³šå°ã¯äž»åŒµããããã«ã¯å¹ããªãããšãåçœããã
ãã¡ãŠãæ°ã¯ãCell Host & Microbeãèªã«çºè¡šããæ°ããè«æã§ããã³ãããŠã€ã«ã¹ãã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ããã®ä»ã®åŒåžåšç³»ãŠã€ã«ã¹ã«å¯Ÿããæ¬¡äžä»£ã¯ã¯ãã³ã®åèããšé¡ããŠããå šèº«æäžããéè€è£œã¯ã¯ãã³ã§ç²èåŒåžåšãŠã€ã«ã¹ã®ã³ã³ãããŒã«ã詊ã¿ãããšã¯ãä»ã®ãšããã»ãšãã©æåããŠããªããããšæžããŠããã
ãã¡ãŠãèªèº«ãç©æ¥µçã«æ³šå°ãæšãé²ããåŸã§ãããã¯ãŒãã¹ããŒãäœæŠã«å¯Ÿããåœã®åºç¯ãªäžæ¯æãèªèããŠãã¢ã¡ãªã«ãäžçããã¡ãŠãã€ã³ãã«ãšã³ã¶æ³šå°ã«ã€ããŠèããããŠããããšã¯å šãŠåã§ãã£ããšèªããŠãã-ãã£ãšïŒã
ä»ãçªç¶ããã¡ãŠãã¯ã以åã¯éã®ããšã䞻匵ããŠããã«ãããããããäžåœè£œãŠã€ã«ã¹æ³šå°ã¯å¹æããªããã€ãŸããå¹ããªããšãã説åŸãããã®ã§ããããã¡ãŠãã®æ°ããç ç©¶ã¯ãèªç¶å ç«ã«é ŒãããšãããæãŸãããšèªããŠããã
ãã€ã³ãã«ãšã³ã¶ãã³ãããŠã€ã«ã¹ïŒäŸãã°COVIDã®åå ãšãªãSARS-CoV-2ïŒã®ãããªåŒåžåšç³»ãŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã¯ãä»ã®ã¯ã¯ãã³ã«æåŸ ãããã¬ãã«ã®æå¹æ§ãéæããå¯èœæ§ã¯æ¥µããŠäœãããšãã¬ãã¥ãŒããæããã§ãããšãšããã¯ã¿ã€ã ã¹ã®ããŒãããã»ãã«ã¯æžããŠããã
ãèè éã¯ãçŸåš6ã¶æããäžã®å šãŠã®å¹Žéœ¢å±€ã«æŒãä»ããããŠããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æå¹æ§ãã2005幎以æ¥ãããã14ããŒã»ã³ãããæå€§60ããŒã»ã³ãã®ç¯å²ã§ããããšã瀺ãCDCããŒã¿ã«æ³šç®ããŠããŸã(17幎é¡ãã°ãããã¯10ããŒã»ã³ããŸã§äžãããå¹³åã¯ã¯ãã³å¹æ(VE)ã¯40ããŒã»ã³ãããããã«äžåã)ãã
ã¯ã¯ãã³ã¯åŒåžåšç³»ãŠã€ã«ã¹ã«ã¯å¹ããªãã以äž
ãŠã€ã«ã¹ã¯åžžã«æ°ãããäºçš®ãããå€çš®ãã«å€ç°ããŠãããããã¯ã¯ãã³ã§ãŠã€ã«ã¹ãå¶åŸ¡ããããšããã®ã¯æããªè¡çºã§ããããšãã¯ã¯ãã³ãå ã®ãŠã€ã«ã¹ã«å¹ãããšããŠãããããã¯å¹ããããã«èŠããŠããå ã®ãŠã€ã«ã¹ã¯ããã«ã¯ã¯ãã³ãåºãæãã®ã§ã圹ã«ç«ããªãã®ã§ãã
ãã¡ãŠãã®è«æã«ããã°ãã...çŸåšæ¿èªãããŠããæé«ã®ã€ã³ãã«ãšã³ã¶ã»ã¯ã¯ãã³ã¯ãä»ã®ã»ãšãã©ã®ã¯ã¯ãã³ã§äºé²å¯èœãªç æ°ã«å¯ŸããŠã¯ãæ¿èªããã®ã«äžååãªãã®ã§ãããããç²èææåã®åŒåžåšç³»ãŠã€ã«ã¹ã®ã©ããããã¯ã¯ãã³ã§å¹æçã«ã³ã³ãããŒã«ãããããšããªãã®ã¯ãé©ãã¹ãããšã§ã¯ãããŸãããã
ããã®å šãç°ãªã2ã€ã®ãŠã€ã«ã¹ã®ã¯ã¯ãã³ã«ã¯å ±éã®ç¹åŸŽããããŸãïŒéå£å ç«ãå ããŠé²åãããŠã€ã«ã¹å€çš®ã«å¯Ÿããäžå®å šã§çåœãªé²åŸ¡ãããããã®ã§ãã
ãã®è«æã¯ããŠã€ã«ã¹ãããŠã€ã«ã¹è¡çãèµ·ããããšãªãã屿ç²èçµç¹ã§åªå¢ã«è€è£œããããšã説æããŠããŸããã€ãŸãããŠã€ã«ã¹ã¯å ç«ç³»ãé©å¿å ç«åå¿ã®å šåãçºæ®ããããšã¯ãªããå®å šã«æçãããŸã§ã«ã¯1é±éããããã
ãã®ææã«ã¯ããŠã€ã«ã¹ã®è€è£œãä»è ãžã®ææãé²ãããšã¯ã§ããªãããããããæš©åè ãã¡ã§ãããã³ãããžã£ãã¯ææãææãé²ãããšãã§ããã圹ã«ç«ããªãããšãèªããŠããã®ã§ããã
ãã¡ãŠãå士ã«ããã°ãã³ããææç察çãšããŠIgGãIgMã®ãããªåŸªç°åæäœã«æ³šç®ããã®ã¯èª€ãã§ãã£ããšã®ããšã§ãããäžæ°éã®ç²èã«ååšããIgAã®ãããªç²èæäœããå ç«ã«ãããŠãã倧ããªåœ¹å²ãæããããšã倿ããã®ã ã
ãåŒåžåšç³»ãŠã€ã«ã¹ææçã«å¯Ÿããç åäœç¹ç°çåå¿ã«ãããç²èåæ³åIgAïŒsIgAïŒã®éèŠæ§ã¯ãã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãRSVããããŠæè¿ã§ã¯SARS-CoV-2ã«ã€ããŠé·ãéèªããããŠããŸãã ããšãè«æã¯æŽã«èª¬æããŠããã
ãã¡ãŠãã§ããããã€ãŠæšé²ããäºé²æ¥çš®ãå šãã®è¶çªã§ãèªç¶å ç«ã®æ¹ããã£ãšè¯ãéžæã§ããããšãåçœããããåŸãªããªã£ãæãäºæ ã¯å€§ããåãããšèšããã§ãããã
ããã¡ãŠã㯠ãã¯ã¯ãã³ ãã倱æã§ãã£ããã®ããã«è£ ã£ãŠããããããã¯çç©å µåšã§ãããåžžã«ãããæå³ããŠããã®ã§ãã-ãããŠãã¡ãŠãã¯ãããåžžã«ç¥ã£ãŠããã®ã ããšãããã³ã¡ã³ãè ã¯æžããŠããããç§ã¯åœŒã«éšãããªãããããªããéšãããã¹ãã§ã¯ãããŸããã圌ã¯èªåã®å°»æããããããšããŠããã®ã ã ãšã